Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2005-6-14
pubmed:abstractText
Environmental cues associated with nicotine delivery are an important part of the stimulus that sustains smoking behavior and is often coupled with craving and relapse; however, the neuronal circuitry and molecular substrates underlying this process are still poorly understood. Exposure to an environment previously associated with rewarding properties of nicotine results in an increase of CREB phosphorylation similar to that seen following nicotine administration, and this response is absent in MOR(-/-) mice. Moreover, a single administration of an opioid receptor antagonist, naloxone, blocks both the conditioned molecular response (CREB phosphorylation) and the conditioned behavioral response (nicotine reward) in a place preference paradigm. Lastly, repeated nicotine administration results in increased expression of MORs. However, this effect, along with rewarding properties of nicotine, is blocked in mice with a targeted disruption in the CREB gene. Together, pharmacologic and genetic manipulations indicate that phosphorylation of CREB and upregulation of functional MORs are required for nicotine-conditioned reward.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0896-6273
pubmed:author
pubmed:issnType
Print
pubmed:day
16
pubmed:volume
46
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
933-43
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:15953421-Analysis of Variance, pubmed-meshheading:15953421-Anesthetics, Local, pubmed-meshheading:15953421-Animals, pubmed-meshheading:15953421-Behavior, Animal, pubmed-meshheading:15953421-Blotting, Northern, pubmed-meshheading:15953421-Blotting, Western, pubmed-meshheading:15953421-Brain, pubmed-meshheading:15953421-Cell Count, pubmed-meshheading:15953421-Cocaine, pubmed-meshheading:15953421-Conditioning, Operant, pubmed-meshheading:15953421-Cyclic AMP Response Element-Binding Protein, pubmed-meshheading:15953421-Dose-Response Relationship, Drug, pubmed-meshheading:15953421-Drug Interactions, pubmed-meshheading:15953421-Enzyme Activation, pubmed-meshheading:15953421-Immunohistochemistry, pubmed-meshheading:15953421-Immunoprecipitation, pubmed-meshheading:15953421-Mice, pubmed-meshheading:15953421-Mice, Inbred C57BL, pubmed-meshheading:15953421-Mice, Knockout, pubmed-meshheading:15953421-Naloxone, pubmed-meshheading:15953421-Narcotic Antagonists, pubmed-meshheading:15953421-Neurons, pubmed-meshheading:15953421-Nicotine, pubmed-meshheading:15953421-Phosphorylation, pubmed-meshheading:15953421-RNA, Messenger, pubmed-meshheading:15953421-Receptors, Opioid, mu, pubmed-meshheading:15953421-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:15953421-Reward, pubmed-meshheading:15953421-Time Factors, pubmed-meshheading:15953421-Tobacco Use Disorder
pubmed:year
2005
pubmed:articleTitle
Mu-opioid receptor and CREB activation are required for nicotine reward.
pubmed:affiliation
Department of Pharmacology, University of Pennsylvania, Philadelphia 19104, USA.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, U.S. Gov't, P.H.S., Research Support, N.I.H., Extramural